Rare Daily Staff RareStone, formerly Citrine Medicine, and Tencent Holdings, a Chinese digital technology platform company, entered a strategic collaboration memorandum to develop a service ecosystem focused on rare disease patients in China. The combined effort will promote education of rare disease, focus social awareness on rare disease, and improve accessibility of medical information and services for rare disease by working together to provide innovative digital solutions to benefit rare disease patients. “It may take several generations of effort to make rare diseases ‘not rare.’ As a company focusing on rare disease solutions, we hold this responsibility on our shoulders…